drugset / Trial / NCT07828470
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of KL0011034 Injection Administered by Continuous Infusion in Healthy Adult Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is a randomized, double-blind, propofol position-controlled trial, evaluating the safety, tolerability, and pharmacodynamic of continuous infusion of KL0011034 injection compared with propofol injectable emulsion for durations of 1 hour, 2 hours, and 3 hours, and evaluating the pharmacokinetic of the KL0011034 injection.
Timeline
- Start
- 2026-10-13
- Primary completion
- 2026-11-13
- Completion
- 2026-11-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KL0011034 | Unknown | — | Intravenous |
| Subject | Propofol | Small molecule | 2 mg/kg | Intravenous |
Indications
No indication recorded.